HEATHER O'CONNELL: Open Payments
NPI 1730550799 · PEORIA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,520 in 208 payments from 30 companies in 2025. Trend: 2023 $2,900 · 2024 $5,570 · 2025 $15,520
Consulting: $6,756Food & beverage: $5,689Travel & lodging: $1,756Speaker / faculty: $1,300Education: $19
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 37 | $10,979 |
| AstraZeneca Pharmaceuticals LP | 21 | $724 |
| Regeneron Healthcare Solutions, Inc. | 12 | $618 |
| Incyte Corporation | 5 | $410 |
| GENZYME CORPORATION | 15 | $335 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $331 |
| CSL Behring | 11 | $293 |
| Grifols USA, LLC | 11 | $286 |
| GlaxoSmithKline, LLC. | 14 | $243 |
| Blueprint Medicines Corporation | 6 | $199 |
Products named: Rhapsido, DUPIXENT, TEZSPIRE, Xembify, AYVAKIT, OPZELURA, Hizentra, Xhance.
Industry payments across AZ — which companies pay providers there.
